Excelsior Correspondent
NEW DELHI, Sept 5 : Union Minister Dr Jitendra Singh today reviewed North India’s first ever Biotech Industrial Park project at Kathua, first ever Cannabis Medicine Project with Canadian collaboration at Indian Institute of Integrative Medicine (IIIM) Jammu and other projects coming up through Council of Scientific & Industrial Research (CSIR), Union Ministry of Science & Technology.
The review meeting was, among others, attended through video conference, by Director General CSIR Dr Shekhar Mande from New Delhi, Advisor to Lieutenant Governor Jammu & Kashmir Rajiv Bhatanagar from Srinagar and Dr D Srinivasa Reddy, Director IIIM from Jammu.
The meeting was also followed by a virtual visit to the site and inspection of the ongoing work on Biotech Park at Gatti near Kathua. The virtual inspection tour was conducted by Senior Scientist from IIIM Jammu Dr Zubair who was also accompanied by local representatives of the area.
While reviewing the project, Dr Jitendra Singh appreciated the fact that the work on the Biotech Industrial Park in Kathua was carrying on in spite of the constraints of COVID pandemic, although the pace was slow. The Minister was informed that the deadline of the completion of the project had got delayed due to COVID related difficulties and the new deadline would possibly be around February 2021.
Dr Singh called for conducting awareness programmes to sensitise people about the new avenues of livelihood, Startup ventures, entrepreneurship and research which will become available when the Biotech Park becomes functional. Spread over an area of around 10.5 acres of land, the benefits of this Biotech Industrial Park will also be available to the neighbouring States of Punjab and Himachal Pradesh.
Referring to the first ever Seed Processing Plant which is almost ready at Kathua, Dr Singh said, the Biotech Park and Seed Processing Plant will be able to supplement each other’s resources.
About the Canadian collaboration Cannabis Medicine Project Dr Singh said, this is the first major foreign investment in Jammu & Kashmir after the creation of Union Territory. Special permission had to be obtained to produce the pain-relief medicine for patients suffering from cancer, diabetes, etc. using Cannabis, which is otherwise restricted for use because of narcotic drug abuse. The medicine prepared from this plant can be utilised even for export to other countries, he added.
Follow our WhatsApp channel
